|
Real-time Estimate
Cboe BZX
15:11:51 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 26.44 USD | -1.42% |
|
+27.04% | - |
| 12:43pm | BlossomHill Therapeutics Q2 Loss Widens | MT |
| 12:14pm | Earnings Flash (BLSM) BlossomHill Therapeutics Posts Q2 Loss $8.75 a Share | MT |
Evolution of the Average Target: BlossomHill Therapeutics, Inc.
Evolution of the Target Price: BlossomHill Therapeutics, Inc.
Changes in Analyst Recommendations: BlossomHill Therapeutics, Inc.
b25baa4a3a3d5b531.cD10j3SLANVL_Pgr5Pr_CjdejkJpE0FpuN0H_tp8P3E.XVNC5k3oa504kbJ-h7zMfFJotg0OIg8F54lrjrA9bwkkZAbGLOM3hHrOsQ~efece09d4c67f416dfbcd34b520a7d48
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +20.06% | |||
| +26.27% | |||||
| +3.16% | |||||
| +27.56% | |||||
| +22.45% | |||||
| +49.02% | |||||
| -5.42% | |||||
| +30.8% | |||||
| -6.03% | |||||
| +9.18% | |||||
| Average | +17.70% | |||||
| Weighted average by Cap. | +20.07% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
26.82USD
Average target price
32.20USD
Spread / Average Target
+20.06%
High Price Target
36.00USD
Spread / Highest target
+34.23%
Low Price Target
28.00USD
Spread / Lowest Target
+4.40%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- BLSM Stock
- Consensus BlossomHill Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
